To Evaluate the Efficacy and Safety of Inhaled Corticosteroids Combined With Bronchodilators and Programmed Death-ligand 1 (PD-L1) Inhibitor Plus Platinum-based Chemotherapy in Patients With Advanced Lung Squamous Cell Carcinoma Complicated With Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT06772454 · RECRUITING
Trial details
- NCT number
- NCT06772454
- Sponsor
- Guangzhou Institute of Respiratory Disease
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-01-01
- Primary completion
- 2025-06-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.